期刊文献+

不同类型冠心病患者血浆氧化低密度脂蛋白及其抗体变化的临床意义 被引量:1

Changs of the plasma oxidized low density lipoprotein and its antibody in patients with different kinds of coronary heart disease and its clinical significance
下载PDF
导出
摘要 目的 探讨急性冠脉综合征 (ACS)、稳定型心绞痛 (SAP)患者血浆血脂、氧化低密度脂蛋白 (OX-L DL)及其抗体 (Anti- OX- L DL)变化在冠状动脉粥样硬化 (AS)发生、发展中的作用及其相关性。方法 分别用酶联免疫吸附法测定 136例冠心病 (ACS组 10 6例 ,SAP30例 )及 5 6例正常对照组的血浆血脂、OX- L DL、Anti- OX-L DL,并进行直线相关性分析。结果  1冠心病组血脂 TC、TG、L DL- C与对照组存在显著差异 (P<0 .0 1)。 2ACS组血浆 OX- L DL及 Anti- OX- L DL与 SAP组、对照组比较 ,P均 <0 .0 1;SAP组与对照组比较上述指标差异无显著性 (P>0 .0 5 )。 3ACS组 OX- L DL与 L DL呈正相关 (r=0 .6 4 2 ,P<0 .0 1) ;Anti- OX- L DL与 L DL无关 (r=0 .341,P>0 .0 5 )。结论 高脂血症是冠心病的绝对危险因素 ;OX- L DL及其抗体在 ACS发病中起重要作用 ;Anti- OX- L DL 作用不依赖于 L DL。 Objective To observing changes of plasma LP,OX-LDL and Anti-OX-LDL in 106 patients with acute coronary syndrome(ACS),30 patients with stable angina pectoris (SAP) and 56 control cases.Methods The plasma levels of LP,OX-LDL and Anti-OX-LDL were measured with enzyme linked immunosorbent assay (ELISA) method respectively,The analysis of linear correlation was performed to estimate the relationship between variables.Results ①Plasma total cholesterol (TC),triglycerides (TG) and low density lipoprotein (LDL) were significant difference between coronary heart disease group and control group respectively (P<0.01).②Plasma OX-LDL and Anti-OX-LDL were significant different between ACS group and SAP group,control group respectively (P<0.01),there was no significant different between SAP group and control group (P>0.05).③Linear correlation analysis showed that ACS plasma OX-LDL in patients with was positively correlated with LDL(r=0.642,P<0.01),but plasma Anti-OX-LDL had no relationship with LDL(r=0.341 P>0.05).Conclusion Plasma LP is the absolute risk factor of CHD.OX-LDL and Anti-OX-LDL play important role in the incidence of AS and heart event.Anti-OX-LDL has independent role.
出处 《山东医药》 CAS 北大核心 2004年第31期4-5,共2页 Shandong Medical Journal
关键词 OX-LDL ACS 血浆 对照组 抗体 氧化低密度脂蛋白 冠心病 SAP 发展 正相关 Coronary heart disease Oxidized low density lipoprotein Antibody against low density lipoprotein
  • 相关文献

参考文献4

二级参考文献13

  • 1[1]Ml M, Gronholdt S, Dalager-Pedersen E F. Coronary atherosclerosis: Determinants of plaque rupture.Eur Heart J, 1998,19(Suppl C):C24-C29.
  • 2[2]Yla-Herttuala S, Palinski W, Rosenfeld M E, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J Clin Invest, 1989,84:1086-1095.
  • 3[3]Kim R S, LaBella F S. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J Lipid Res, 1987,28:1110-1117.
  • 4[4]Arja T E, Outi N, Seppo L, et al. Autoantibodies against oxidized low density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol, 2000,20:204-209.
  • 5[5]Danial S. Lewis a conner memorial lecture-oxidative modification of LDL and atherogenesis.Circulation, 1997,95:1062-1071.
  • 6[6]Wu R, Nityanand S, Berglund L, et al. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol, 1997,17:3159-3163.
  • 7[7]Tetsuo S, Yoshiki N, Mariko F, et al. Inverse relationship between circulating oxidized low density lipoprotein (ox-LDL) and anti-ox LDL antibody levels in healthy subjects. Atherosclerosis, 2000,148:171-177.
  • 8汤佩麟.高半胱氨酸与动脉粥样硬化关系的研究进展[J].心血管病学进展,1997,18(2):95-97. 被引量:16
  • 9朱燕青,张晨晖,陈光慧.同型半胱氨酸: 动脉粥样硬化的一个独立的危险因素[J].生理科学进展,1997,28(4):334-336. 被引量:20
  • 10王玉芳.同型半胱氨酸致动脉粥样硬化的机制[J].中国动脉硬化杂志,1998,6(3):259-263. 被引量:51

共引文献45

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部